California Institute of Regenerative Medicine Awards - Additional Information (Details) - California Institute Of Regenerative Medicine
$ in Millions |
1 Months Ended |
12 Months Ended |
|
Dec. 31, 2021
USD ($)
|
Sep. 30, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
|
Dec. 31, 2021
USD ($)
Time
|
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
|
|
|
|
| Revenue sharing multiple | Time |
|
|
|
9
|
| Period to exercise loan option upon food and drug administration authorization |
|
|
|
10 days
|
| Repayment period |
|
|
|
10 days
|
| Repayment of awards percentage |
|
|
|
60.00%
|
| P B C M A101 Phase1 Clinical Trial |
|
|
|
|
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
|
|
|
|
| Award received |
|
|
$ 19.8
|
|
| Proceeds form award received upon achievement of development milestones |
$ 19.7
|
|
|
|
| Milestone payments receivable |
0.1
|
|
|
$ 0.1
|
| P-PSMA-101 program |
|
|
|
|
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
|
|
|
|
| Award received |
|
$ 4.0
|
|
|
| Proceeds form award received upon achievement of development milestones |
$ 4.0
|
|
|
|
| LIBOR |
|
|
|
|
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
|
|
|
|
| Debt instrument basis spread on variable rate |
|
|
|
10.00%
|